Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy

Ultrasound in Obstetrics and Gynecology

Volumn 47, Issue 6, 2016, Pages 705-711

  Sarno, L ^a   Revello, R ^a   Hanson, E ^a   Akolekar, R ^a   Nicolaides, K H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

cell free DNA; fetal fraction; first trimester screening; non invasive prenatal testing; trisomy 21; twin pregnancy

Indexed keywords

DNA;

ADULT; BLOOD; CELL FREE SYSTEM; CHROMOSOME 13; CHROMOSOME 18; CHROMOSOME 21; DNA SEQUENCE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRISOMY; TWIN PREGNANCY;

ADULT; CELL-FREE SYSTEM; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 21; DNA; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY, TWIN; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TRISOMY;

EID: 84971523918     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.15913     Document Type: Article

References (26)

1. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH,. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249-266.
2. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki G,. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012; 32: 730-734.
3. Gil MM, Quezada MS, Bregant B, Syngelaki A, Nicolaides KH,. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther 2014; 35: 204-211.
4. Gromminger S, Yagmur E, Erkan S, Nagy S, Schock U, Bonnet J, Smerdka, P, Ehrich M, Wegner RD, Holfmann W, and, Stumm M,. Fetal aneuploidy detection by cell-free DNA sequencing for multiple pregnancies and quality issues with vanishing twins. J Clin Med 2014; 3: 679-692.
5. Bevilacqua E, Gil MM, Nicolaides KH, Ordon Ez E, Cirigliano V, Dierickx H, Willems PJ, Jani JC,. Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies. Ultrasound Obstet Gynecol 2015; 45: 61-66
6. Lau TK, Jiang F, Chan MK, Zhang H, Lo PS, Wang W,: Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies. J Matern Fetal Neonatal Med 2013; 26: 434-437.
7. Huang X, Zheng J, Chen M, Zhao Y, Zhang C, Liu L, Xie W, Shi S, WeiY, Lei D, Xu C, WuQ, GuoX, Shi X, ZhouY, LiuQ, GaoY, Jiang F, ZhangH, Su F, GeH, Li X, Pan X, Chen S, Chen F, Fang Q, Jiang H, Lau TK, Wang W,. Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014; 34: 335-340.
8. Wright D, Wright A, Nicolaides KH,. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol 2015; 45: 48-54.
9. Qu JZ, Leung TY, Jiang P, Liao GJ, Cheng YK, Sun H, Chiu RW, Chan KC, Lo YM,. Noninvasive prenatal determination of twin zygosity by maternal plasma DNA analysis. Clin Chem 2013; 59: 427-435.
10. Leung TY, Qu JZ, Liao GJ, Jiang P, Cheng YK, Chan KC, Chiu RW, Lo YM,. Noninvasive twin zygosity assessment and aneuploidy detection by maternal plasma DNA sequencing. Prenat Diagn 2013; 33: 675-681.
11. Struble CA, Syngelaki A, Oliphant A, Song K, Nicolaides KH,. Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis. Fetal Diagn Ther 2014; 35: 199-203.
12. Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH,. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol 2016; 47: 45-52.
13. Quezada MS, Gil MM, Francisco C, Oròsz G, Nicolaides KH,. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks. Ultrasound Obstet Gynecol 2015; 45: 36-41.
14. Robinson HP, Fleming JE,. A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
15. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH,. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 1996; 7: 421-423.
16. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
17. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH,. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502.
18. Madsen HN, Ball S, Wright D, Tørring N, Petersen OB, Nicolaides KH, Spencer K,. A reassessment of biochemical marker distributions in trisomy 21-affected and unaffected twin pregnancies in the first trimester. Ultrasound Obstet Gynecol 2011; 37: 38-47.
19. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A,. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 319.e1-9.
20. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH,. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis. Ultrasound Obstet Gynecol 2013; 41: 21-25.
21. Revello R, Sarno L, Ispas A, Akolekar R, Nicolaides KH,. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol 2016; 47: 698-704.
22. Amor DJ, Xu JX, Halliday JL, Francis I, Healy DL, Breheny S, Baker HW, Jaques AM,. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 2009; 24: 1330-1308.
23. Engels MA, Pajkrt E, Groot DT, Schats R, Twisk JW, van Vugt JM,. Validation of correction factors for serum markers for first-trimester Down syndrome screening in singleton pregnancies conceived with assisted reproduction. Fetal Diagn Ther 2013; 34: 217-224.
24. Chaveeva P, Carbone IF, Syngelaki A, Akolekar R, Nicolaides KH,. Contribution of method of conception on pregnancy outcome after the 11-13 weeks scan. Fetal Diagn Ther 2011; 30: 9-22.
25. Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH,. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol 2015; 213: 62.e1-10.
26. Evans MI, Goldberg JD, Dommergues M, Wapner RJ, Lynch L, et al., Efficacy of second-trimester selective termination for fetal abnormalities: International collaborative experience among the world's largest centers. Am J Obstet Gynecol 1994; 171: 90-94.